# FDA Inspection 1242486 - Ningbo Renjian Pharmaceutical Group Co., Ltd - May 17, 2024

Source: https://www.keypedia.com/records/fda_inspections/ningbo-renjian-pharmaceutical-group-co-ltd/b524f835-e506-4038-901a-816899d0f360
Source feed: FDA_Inspections

> FDA Inspection 1242486 for Ningbo Renjian Pharmaceutical Group Co., Ltd on May 17, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1242486
- Company Name: Ningbo Renjian Pharmaceutical Group Co., Ltd
- Inspection Date: 2024-05-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1242486 - 2024-05-17](https://www.keypedia.com/records/fda_inspections/ningbo-renjian-pharmaceutical-group-co-ltd/ec511e20-e589-4117-8a19-1922f10572e9)
- [FDA Inspection 934139 - 2015-06-02](https://www.keypedia.com/records/fda_inspections/ningbo-renjian-pharmaceutical-group-co-ltd/61e07f5b-20cb-4d4b-b66e-2716d49dfabe)
- [FDA Inspection 934139 - 2015-06-02](https://www.keypedia.com/records/fda_inspections/ningbo-renjian-pharmaceutical-group-co-ltd/70bd6b04-554c-42c8-afc7-05a7ddee29af)

Company: https://www.keypedia.com/companies/ningbo-renjian-pharmaceutical-group-co-ltd/2ab3e635-58da-471d-ac3c-fea24c39ca52

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c